Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
The results from the analysis of the ADVANCE trial and post-intervention program ADVANCE-ON are presented in this article. These studies are dedicated to study the effect of intensive glycemic control on the incidence of micro- and macrovascular events in patients with type 2 diabetes mellitus and e...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/fc8ec502d4c34c8ba368918a15a2a12e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:fc8ec502d4c34c8ba368918a15a2a12e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:fc8ec502d4c34c8ba368918a15a2a12e2021-11-14T09:00:20ZResults of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?2072-03512072-037810.14341/DM7696https://doaj.org/article/fc8ec502d4c34c8ba368918a15a2a12e2015-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7696https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The results from the analysis of the ADVANCE trial and post-intervention program ADVANCE-ON are presented in this article. These studies are dedicated to study the effect of intensive glycemic control on the incidence of micro- and macrovascular events in patients with type 2 diabetes mellitus and evaluation of long-term results of intensive glycemic control. We discuss the progress of views on the impact of glycemic control on the development of cardiovascular complications. According to the analysis of the research results, gliclazide MR is safe in patients with type 2 diabetes at high risk for cardiovascular complications.Marina Vladimirovna ShestakovaYuriy Shavkatovich KhalimovEndocrinology Research Centrearticletype 2 diabetesadvanceadvance-ondrugs sulfonylureasgliclazideNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 18, Iss 4, Pp 119-124 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
type 2 diabetes advance advance-on drugs sulfonylureas gliclazide Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
type 2 diabetes advance advance-on drugs sulfonylureas gliclazide Nutritional diseases. Deficiency diseases RC620-627 Marina Vladimirovna Shestakova Yuriy Shavkatovich Khalimov Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| description |
The results from the analysis of the ADVANCE trial and post-intervention program ADVANCE-ON are presented in this article. These studies are dedicated to study the effect of intensive glycemic control on the incidence of micro- and macrovascular events in patients with type 2 diabetes mellitus and evaluation of long-term results of intensive glycemic control. We discuss the progress of views on the impact of glycemic control on the development of cardiovascular complications. According to the analysis of the research results, gliclazide MR is safe in patients with type 2 diabetes at high risk for cardiovascular complications. |
| format |
article |
| author |
Marina Vladimirovna Shestakova Yuriy Shavkatovich Khalimov |
| author_facet |
Marina Vladimirovna Shestakova Yuriy Shavkatovich Khalimov |
| author_sort |
Marina Vladimirovna Shestakova |
| title |
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| title_short |
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| title_full |
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| title_fullStr |
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| title_full_unstemmed |
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| title_sort |
results of the advance trial and interventional observational program advance-on: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed? |
| publisher |
Endocrinology Research Centre |
| publishDate |
2015 |
| url |
https://doaj.org/article/fc8ec502d4c34c8ba368918a15a2a12e |
| work_keys_str_mv |
AT marinavladimirovnashestakova resultsoftheadvancetrialandinterventionalobservationalprogramadvanceonwhetherourunderstandingoftherelationshipofglycemicfactorsandtheriskofvascularcomplicationsinpatientswithtype2diabeteshaschanged AT yuriyshavkatovichkhalimov resultsoftheadvancetrialandinterventionalobservationalprogramadvanceonwhetherourunderstandingoftherelationshipofglycemicfactorsandtheriskofvascularcomplicationsinpatientswithtype2diabeteshaschanged |
| _version_ |
1718429567278907392 |